- Investing Ideas
- Egyptian Pharmaceuticals & Biotech Undervalued based on future growth
Egyptian Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
Egyptian International Pharmaceutical Industries
Market Cap: ج.م13.6b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م80.74
7D
3.2%
1Y
62.8%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م8.7b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م4.37
7D
-6.2%
1Y
36.4%